Digistain
In the global fight against breast cancer, Digistain stands at the forefront, offering a beacon of hope to millions. Our journey began at Imperial College London, where ground-breaking research gave birth to a technology poised to revolutionize breast cancer diagnostics. The Challenge: Every year, breast cancer affects 2.3 million individuals globally. Post-surgery, 60% of patients are advised to undergo genomic testing, an expensive and time-consuming process monopolized by a single lab in the
Y Combinator
yc-company-directory #1949In the global fight against breast cancer, Digistain stands at the forefront, offering a beacon of hope to millions. Our journey began at Imperial College London, where ground-breaking research gave birth to a technology poised to revolutionize breast cancer diagnostics. The Challenge: Every year, breast cancer affects 2.3 million individuals globally. Post-surgery, 60% of patients are advised to undergo genomic testing, an expensive and time-consuming process monopolized by a single lab in the
sourceDigistain is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Digistain
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Signatur Biosciences
match 57We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.
shared product terms: breast, cancer, diagnostic, test; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
Spect
match 49Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.
shared product terms: million, globally, patient, expensive; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
Mytos
match 49Mytos builds robots for manufacturing human cells. Operators input stem cells, and our platform turns them into specific cells such as neurons and heart cells over multiple weeks. Last year, patients were cured of Parkinson’s, vision loss, and Type 1 diabetes using stem-cell derived cells. We need 1000x the global capacity to produce these cells, and treat millions of patients. But today these Regenerative Medicines are produced by hand, meaning they’re too expensive and don’t scale. Mytos has f
shared product terms: global, million, year, patient; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
Muzz
match 41Muslims don't date - they marry. Muzz is where single Muslims meet. We are the world's biggest Muslim dating app, boasting over 10 million members and over 500,000 weddings, Muzz is making a real difference in the huge yet untapped global Muslim demographic. Shahzad Younas (London, UK) is the founder and CEO of Muzz. Formerly a Vice President in Equity Portfolio Trading at investment bank Morgan Stanley for 9 years, Shahzad quit his career to fully focus on building a high quality mobile app to
shared product terms: global, million, london, year; shared affiliation: Y Combinator
TYBR Health
match 36TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.
shared product terms: surgery, million, undergo, year; same category: Healthcare; shared affiliation: Y Combinator
LSK Technologies
match 25A diagnostic lab in a box
shared product terms: diagnostic, lab; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator